Time course of the GABAergic effects of vigabatrin: Is the time course of brain GABA related to platelet GABA-transaminase inhibition?

Epilepsia

Volumn 40, Issue 8, 1999, Pages 1062-1069

  Valdizán, Elsa M ^a   García, Agueda P ^a   Armijo, Juan A ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Epilepsy; GABA; GABA transaminase; Platelets; Vigabatrin

Indexed keywords

4 AMINOBUTYRATE AMINOTRANSFERASE; 4 AMINOBUTYRIC ACID; VIGABATRIN;

4 AMINOBUTYRIC ACID BRAIN LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; EPILEPSY; GABAERGIC SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOCYTE FUNCTION;

EID: 0032780590     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1999.tb00820.x     Document Type: Article

References (33)

1. Jung MJ, Lippert B, Metcalf BW, Böhlen P, Schechter PJ. γ-Vinyl GABA (4 amino-hex-5-enoic acid), a new selective irreversible inhibitor of GABA-T: effects on brain GABA metabolism in mice. J Neurochem 1977;29:797-802.
2. Lippert B, Metcalf BW, Jung MJ, Casara P. 4-Amino-hex-5-enoic acid, a selective catalytic inhibitor of 4-aminobutyric-acid aminotransferase in mammalian brain. Eur J Biochem 1977;74:441-5.
3. Schechter PJ, Trainer Y, Jung MJ, Böhlen P. Audiogenic seizure protection by elevated brain GABA concentration in mice: effects of γ-acetylenic-GABA and γ-vinyl-GABA, two irreversible GABA-T inhibitors. Eur J Pharmacol 1977;45:319-28.
4. Perry TL, Kish SJ, Hansen S. γ-Vinyl-GABA: effects of chronic administration on the metabolism of GABA and other amino compounds in rat brain. J Neurochem 1979;32:1641-5.
5. Löscher W. Effect of inhibitors of GABA transaminase on the synthesis, binding, uptake, and metabolism of GABA. J Neurochem 1980;34:1603-8.
6. Porter TG, Martin DL. Evidence for feedback regulation of glutamate decarboxylase by γ-aminobutyric acid. J Neurochem 1984; 43:1464-7.
7. Valdizán EM, Armijo JA. Effects of single and multiple increasing doses of vigabatrin on brain GABA metabolism and correlation with vigabatrin plasma concentration. Biochem Pharmacol 1992; 43:2143-50.
8. Bernasconi R, Klein M, Martin P, et al. γ-Vinyl GABA: comparison of neurochemical and anticonvulsant effects in mice. J Neural Transm 1988;72:213-33.
9. Valdizán EM, Armijo JA. Relationship between platelet and brain GABA-transaminase inhibition by single and multiple doses of vigabatrin in rats. Epilepsia 1991;32:735-42.
10. Löscher W. Effect of inhibitors of GABA aminotransferase on the metabolism of GABA in brain tissue and synaptosomal fraction. J Neurochem 1981;36:1521-7.
11. Gale K. Role of the substantia nigra in GABA-mediated anticonvulsant actions. In: Delgado-Escueta AV, Ward AA, Woodbury DM, Porter RJ, eds. Advances in neurology. New York: Raven Press, 1986:343-64.
12. Jung MJ, Palfreyman MG. Vigabatrin: mechanisms of action. In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic drugs. 4th ed. New York: Raven Press, 1995:903-13.
13. Gram L, Lyon BB, Dam M. γ-Vinyl-GABA: a single-blind trial in patients with epilepsy. Acta Neurol Scand 1983;68:34-9.
14. Gram L, Klosterskov P, Dam M. γ-Vinyl GABA: a double-blind placebo-controlled trial in partial epilepsy. Ann Neurol 1985;17: 262-6.
15. Browne TR, Mattson RH, Penry JK, et al. Vigabatrin for refractory complex partial seizures: multicenter single-blind study with long-term follow-up. Neurology 1987;37:184-9.
16. Sivenius MRJ, Ylinen A, Murros K, Matilainen R, Riekkinen P. Double-blind dose reduction study of vigabatrin in complex partial epilepsy. Epilepsia 1987;28:688-92.
17. Mumford JP, Dam M. Meta-analysis of European placebo controlled studies of vigabatrin in drug resistant epilepsy. Br J Clin Pharmacol 1989;27(suppl 1):101-7.
18. Arteaga R, Herranz JL, Valdizán EM, Armijo JA. γ-Vinyl GABA (vigabatrin): relationship between dosage, plasma concentration, platelet GABA-transaminase inhibition, and seizure reduction in epileptic children. Epilepsia 1992;33:923-31.
19. White HL. 4-Aminobutyrate-2-oxoglutarate aminotransferase in blood platelets. Science 1979;205:696-8.
20. White HL, Faison LD. GABA-T in blood platelets: comparison with GABA-T of other tissues. Brain Res 1980;5(suppl 12):115-9.
21. Bolton JB, Rimmer E, Williams J, Richens A. The effect of vigabatrin on brain and platelet GABA-transaminase activities. Br J Clin Pharmacol 1989;27(suppl 1):35-42.
22. Rimmer EM, Kongola G, Richens A. Inhibition of the enzyme, GABA-aminotransferase in human platelets by vigabatrin, a potential antiepileptic drug. Br J Clin Pharmacol 1988;25:251-9.
23. Turnell DC, Cooper JDH. Rapid assay for amino acids in serum or urine by pre-column derivatization and reversed-phase liquid chromatography. Clin Chem 1982;28:527-31.
24. Lowe IP, Robins E, Eyerman S. The fluorimetric measurement of glutamic decarboxylase and its distribution in brain. J Neurochem 1958;3:8-18.
25. Lowry OH, Rosebrough NJ, Fair AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193: 265-75.
26. Eslami M, Stuart JD, Dean RW. Analysis of taurine in blood plasma of epileptic patients using an improved isocratic HPLC method for amino acids. J Liquid Chromatogr 1987;10:977-95.
27. Abdul-Ghani AS, Coutinho-Netto J, Bradford HF. The action of γ-vinyl-GABA and γ-acetylenic-GABA on the resting and stimulated release of GABA in vivo. Brain Res 1980;191:471-81.
28. Gram L, Larsson OM, Johnsen AH, Schousboe A. Effects of valproate, vigabatrin and aminooxyacetic acid on release of endogenous and exogenous GABA from cultured neurons. Epilepsy Res 1988;2:87-95.
29. Gram L, Larsson OM, Johnsen A, Schousboe A. Experimental studies of the influence of vigabatrin on the GABA system. Br J Clin Pharmacol 1989;27(suppl 1):13-7.
30. Abdul-Ghani AS, Norris PJ, Smith CCT, Bradford HF. Effects of γ-acetylenic GABA and γ-vinyl GABA on synaptosomal release and uptake of GABA. Biochem Pharmacol 1981;30:1203-9.
31. Löscher W, Fassbender CP, Gram L, Gramer M, Horstermann D, Zahner B, Stefan H. Determination of GABA and vigabatrin in human plasma by a rapid and simple HPLC method: correlation between clinical response to vigabatrin and increase in plasma GABA. Epilepsy Res 1993;14:245-55.
32. Kälviäinen R, Halonen T, Pitkänen A, Riekkinen PJ. Amino acid levels in the cerebrospinal fluid of newly diagnosed epileptic patients: effect of vigabatrin and carbamazepine monotherapies. J Neurochem 1993;60:1244-50.
33. Riekkinen PJ, Ylinen A, Halonen T, Sivenius J, Pitkänen A. Cerebrospinal fluid GABA and seizure control with vigabatrin. Br J Clin Pharmacol 1989;27:87-94.